Sakao Yukinori, Miyamoto Hideaki, Oh Shiaki, Takahashi Nobumasa, Inagaki Tomoya, Miyasaka Yoshikazu, Akaboshi Taku, Sakuraba Motoki
Department of General Thoracic Surgery, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
J Thorac Oncol. 2008 Sep;3(9):958-62. doi: 10.1097/JTO.0b013e31818396e0.
In this retrospective study, we clarified the impact of smoking on prognosis and the association of clinicopathological factors, particularly histologic subtype, in patients with small adenocarcinoma of the lung.
Between 1996 and December 2006, 121 patients presenting with adenocarcinomas that had a diameter </=2 cm were analyzed. The clinicopathological records of the patients were examined for age, gender, nodal status (c-N and p-N), tumor size, serum carcinoembryonic antigen level, histologic subtype, and smoking history. A histologic subtype was defined using a modified World Health Organization classification. These subtypes are bronchioloalveolar carcinoma (BAC), adenocarcinoma with little or no BAC component (Non or min BAC), and mixed bronchioloalveolar carcinoma with other adenocarcinoma components.
The overall 5-year survival rates were 94.4% for never-smokers (N = 55) and 79.2% for smokers (N = 66) (p = 0.05). Cancer-specific 5-year survival rates were 98.0% for never-smokers and 80.4% for smokers (p = 0.03). Gender, serum carcinoembryonic antigen level, and histologic subtype were significantly associated with smoking status. Histologic subtype (Non or min BAC) was the only significant prognostic factor in multivariate analyses. The prevalence of smoking by histologic subtype was 27.3% for BAC, 43.2% for mixed bronchioloalveolar carcinoma, and 74.6% for Non or min BAC. The prevalence was significantly higher in Non or min BAC than in the others. Furthermore, the smoking index (daily cigarette consumption times years of smoking) was significantly higher in Non or min BAC than in the other two subtypes. In addition, patients with a high smoking index showed a greater percentage of Non or min BAC subtypes. Finally, male gender was associated with Non or min BAC independent of smoking status (p = 0.03).
When adenocarcinomas were small (diameter </=2 cm) cigarette smoking and male gender were associated with Non or min BAC histologic subtypes, which are thought to have more aggressive biologic features resulting in poorer outcome compared with other subtypes.
在这项回顾性研究中,我们阐明了吸烟对肺小腺癌患者预后的影响以及临床病理因素,尤其是组织学亚型之间的关联。
分析1996年至2006年12月期间121例直径≤2 cm腺癌患者的情况。检查患者的临床病理记录,包括年龄、性别、淋巴结状态(c-N和p-N)、肿瘤大小、血清癌胚抗原水平、组织学亚型和吸烟史。组织学亚型采用改良的世界卫生组织分类法定义。这些亚型为细支气管肺泡癌(BAC)、几乎无或无BAC成分的腺癌(非BAC或微小BAC)以及具有其他腺癌成分的混合性细支气管肺泡癌。
从不吸烟者(N = 55)的总体5年生存率为94.4%,吸烟者(N = 66)为79.2%(p = 0.05)。癌症特异性5年生存率从不吸烟者为98.0%,吸烟者为80.4%(p = 0.03)。性别、血清癌胚抗原水平和组织学亚型与吸烟状态显著相关。组织学亚型(非BAC或微小BAC)是多因素分析中唯一显著的预后因素。按组织学亚型划分的吸烟率,BAC为27.3%,混合性细支气管肺泡癌为43.2%,非BAC或微小BAC为74.6%。非BAC或微小BAC的吸烟率显著高于其他亚型。此外,非BAC或微小BAC的吸烟指数(每日吸烟支数×吸烟年数)显著高于其他两种亚型。此外,吸烟指数高的患者中,非BAC或微小BAC亚型的比例更高。最后,男性性别与非BAC或微小BAC相关,且与吸烟状态无关(p = 0.03)。
当腺癌较小时(直径≤2 cm),吸烟和男性性别与非BAC或微小BAC组织学亚型相关,与其他亚型相比,这些亚型被认为具有更具侵袭性的生物学特征,导致预后较差。